Investigation of the Cultural Adaptation, Validity, and Reliability of the Turkish Version of the CAP Questionnaire
1 other identifier
observational
300
1 country
1
Brief Summary
The "CAP questionnaire," developed by modifying the CAP-Knee questionnaire to assess potential nociplastic pain features in painful musculoskeletal disorders, has been described. The "CAP questionnaire" is used in people with musculoskeletal pain and diagnostic subgroups of osteoarthritis, back pain, and fibromyalgia. There is no Turkish version of the CAP questionnaire. This study aims to investigate the cultural adaptation, validity, and reliability of the Turkish version of the "CAP questionnaire."
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 28, 2024
CompletedFirst Submitted
Initial submission to the registry
February 9, 2025
CompletedFirst Posted
Study publicly available on registry
February 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 28, 2027
February 13, 2025
November 1, 2024
3 years
February 9, 2025
February 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Central Aspects of Pain Questionnaire (CAP)
The CAP questionnaire consists of eight items assessing each of the eight characteristics linked to the central mechanisms of knee pain over the past week. These items assess neuropathic-like pain, fatigue, cognition, catastrophizing, anxiety, depression, sleep, and widespread pain.
Three months
Secondary Outcomes (6)
BETY-Biopsychosocial Questionnaire
Three months
Hospital Anxiety Depression Scale (HADS)
Three months
Health Assessment Questionnaire (HAQ)
Three months
Pain Catastrophizing Scale (PCS)
Three months
Central Sensitisation Inventory (CSI)
Three months
- +1 more secondary outcomes
Study Arms (3)
Individuals with osteoarthritis
Individuals with back pain
Individuals with fibromyalgia
Interventions
Questionnaire application
Eligibility Criteria
The study population will consist of individuals who come to the university hospital for routine controls.
You may qualify if:
- People with musculoskeletal pain and in diagnoses with OA, back pain, or FM
- Above 18 years of age
- Informed consent of the participant
You may not qualify if:
- Diagnosis of uncontrolled/other clinically significant diseases (chronic obstructive pulmonary disease, congestive heart failure, endocrine system diseases, neurological, psychological diseases, etc.)
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Altındağ, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, PT, PhD(c)
Study Record Dates
First Submitted
February 9, 2025
First Posted
February 13, 2025
Study Start
November 28, 2024
Primary Completion (Estimated)
November 28, 2027
Study Completion (Estimated)
November 28, 2027
Last Updated
February 13, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
Will not be shared to protect the data of individuals